Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1990--January 31, 1993
This report describes the author`s continuing long term goal of promoting nuclear medicine applications by improving the scientific basis for tumor diagnosis treatment and treatment follow-up based on the use of cyclotron produced radiotracers in oncology. The program has 3 interactive components: Radiochemistry /Cyclotron; Pharmacology; and Immunology. An essential strategy is as follows: novel radionuclides and radiotracers developed in the Radiochemistry/Cyclotron section under the DOE grant during the 1989--1992 grant period, will be employed in the Pharmacology and Immunology sections of the DOE grant during the 1992--1995 grant period. The development of novel radionuclides and tracers is of course useful in and of itself, but their utility is greatly enhanced by the interaction with the immunology and pharmacology components of the program.
- Research Organization:
- Sloan-Kettering Inst. for Cancer Research, New York, NY (United States)
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- FG02-86ER60407
- OSTI ID:
- 10177676
- Report Number(s):
- DOE/ER/60407--7; ON: DE92040310
- Country of Publication:
- United States
- Language:
- English
Similar Records
Improving cancer treatment with cyclotron produced radionuclides
Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1992--July 15, 1995
Improving cancer treatment with cyclotron produced radionuclides. Progress report
Technical Report
·
Tue Aug 04 00:00:00 EDT 1992
·
OSTI ID:7262962
Improving cancer treatment with cyclotron produced radionuclides. Comprehensive progress report, February 1, 1992--July 15, 1995
Technical Report
·
Mon Jul 17 00:00:00 EDT 1995
·
OSTI ID:171316
Improving cancer treatment with cyclotron produced radionuclides. Progress report
Technical Report
·
Sun Oct 31 23:00:00 EST 1993
·
OSTI ID:10118877